Posted by Michael Wonder on 10 Apr 2017
QUT, MTPConnect and industry partnership will help to ensure Australia stays globally competitive
10 April 2017 - Medicines Australia warmly welcomes the commencement of The Bridge Program – an initiative of a consortium of Australian innovative pharmaceutical companies and Medicines Australia, together with QUT and Medical Technologies and Pharmaceutical Growth Centre (MTPConnect) – who will translate Australia’s impressive innovation and discovery research into the marketplace.
The Bridge Program will commence in June this year for 100 participants and will also give two participants a travel scholarship to visit overseas pharmaceutical research facilities and develop global experience and business networks.
This industry-led initiative will create commercialisation opportunities for Australia’s bioscience research sphere and Australia’s pharmaceutical and biotechnology sectors.
